cdri 85-287 has been researched along with diethylstilbestrol in 2 studies
| Studies (cdri 85-287) | Trials (cdri 85-287) | Recent Studies (post-2010) (cdri 85-287) | Studies (diethylstilbestrol) | Trials (diethylstilbestrol) | Recent Studies (post-2010) (diethylstilbestrol) |
|---|---|---|---|---|---|
| 22 | 0 | 3 | 8,585 | 322 | 491 |
| Protein | Taxonomy | cdri 85-287 (IC50) | diethylstilbestrol (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 12.5893 | |
| Estrogen receptor | Homo sapiens (human) | 0.1312 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.67 | |
| Adenosine receptor A3 | Homo sapiens (human) | 2.208 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.963 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
| Substance-K receptor | Homo sapiens (human) | 9.553 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 7.763 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 5.6 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.67 | |
| Thromboxane-A synthase | Homo sapiens (human) | 4.359 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 4.79 | |
| Adenosine receptor A2a | Homo sapiens (human) | 9.013 | |
| Adenosine receptor A1 | Homo sapiens (human) | 2.856 | |
| Mu-type opioid receptor | Homo sapiens (human) | 5.778 | |
| D(3) dopamine receptor | Homo sapiens (human) | 8.796 | |
| Delta-type opioid receptor | Homo sapiens (human) | 2.718 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 4.563 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.14 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.071 | |
| Aldehyde oxidase | Homo sapiens (human) | 0.46 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.1588 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kon, OL; Ng, SC; Sim, KY; Teo, CC | 1 |
| Dwivedi, A; Kamboj, VP; Setty, BS; Singh, MM; Sreenivasulu, S | 1 |
2 other study(ies) available for cdri 85-287 and diethylstilbestrol
| Article | Year |
|---|---|
Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis.
Topics: Benzofurans; Binding Sites; Binding, Competitive; Cell Division; Cell Line; Cholesterol; Estrogen Antagonists; Humans; Ligands; Receptors, Estrogen; Thymidine | 1992 |
CDRI-85/287, a novel antiestrogen and antiimplantation agent: biological profile and interaction with the estrogen receptors in immature rat uterus.
Topics: Animals; Benzopyrans; Cell Nucleus; Corpus Luteum; Cytosol; Diethylstilbestrol; Embryo Implantation; Estradiol; Estrogen Antagonists; Female; Organ Size; Ovariectomy; Piperidines; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Estrogen; Sexual Maturation; Uterus | 1992 |